Galecto Inc (GLTO)
0.78
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.7888
+0.01
(+1.13%)
After-Hours: 20:00
Galecto Total Liabilities (Quarterly): 5.896M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.896M |
September 30, 2023 | 12.67M |
June 30, 2023 | 15.10M |
March 31, 2023 | 14.30M |
December 31, 2022 | 11.44M |
September 30, 2022 | 9.298M |
June 30, 2022 | 7.793M |
March 31, 2022 | 7.616M |
Date | Value |
---|---|
December 31, 2021 | 4.992M |
September 30, 2021 | 6.254M |
June 30, 2021 | 5.39M |
March 31, 2021 | 6.084M |
December 31, 2020 | 6.107M |
September 30, 2020 | 8.87M |
June 30, 2020 | 3.894M |
December 31, 2019 | 8.138M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.894M
Minimum
Jun 2020
15.10M
Maximum
Jun 2023
8.365M
Average
7.704M
Median
Total Liabilities (Quarterly) Benchmarks
Novo Nordisk A/S | 30.87B |
Genmab A/S | 546.23M |
Ascendis Pharma A/S | 1.074B |
Evaxion Biotech AS | 14.68M |
IO Biotech Inc | 17.56M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 38.23M |
Shareholders Equity (Quarterly) | 32.33M |